XML 19 R2.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
Sep. 30, 2018
Dec. 31, 2017
ASSETS    
Cash and cash equivalents $ 511,242 $ 312,727
Grant funds and other receivables 14,757 59,758
Prepaid expenses and other current assets 70,188 75,589
Total current assets 596,187 448,074
Property and equipment, net 16,270 31,151
Deposits 11,010 11,010
Total assets 623,467 490,235
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIENCY)    
Accounts payable 147,947 77,581
Accrued expenses (Note 6) 1,149,758 733,711
Current portion of note payable 7,294
Total current liabilities 1,304,999 811,292
Note payable, net of current portion 42,706
Total liabilities 1,347,705 811,292
Commitments (Note 8)
Stockholders’ equity (deficiency):    
Common stock, $.001 par value: Authorized shares – 600,000,000 Issued and outstanding shares – 178,403,476 and 106,736,810 at September 30, 2018 and December 31, 2017 178,403 106,737
Additional paid-in capital 36,830,813 35,589,911
Accumulated deficit (39,842,539) (37,916,790)
Total stockholders’ equity (deficiency) (724,238) (321,057)
Total liabilities and stockholders’ equity (deficiency) 623,467 490,235
Series B Convertible Preferred Stock [Member]    
Stockholders’ equity (deficiency):    
Convertible Preferred Stock 76,095 76,095
Series C Convertible Preferred Stock [Member]    
Stockholders’ equity (deficiency):    
Convertible Preferred Stock 842,990 842,990
Series D Convertible Preferred Stock [Member]    
Stockholders’ equity (deficiency):    
Convertible Preferred Stock 980,000
Series E Convertible Preferred Stock [Member]    
Stockholders’ equity (deficiency):    
Convertible Preferred Stock $ 1,190,000